<DOC>
	<DOC>NCT01626768</DOC>
	<brief_summary>The Medtronic Market-Released DF4 Lead Imaging Study is a prospective, non-randomized study, multi-center clinical investigation. The purpose of this clinical investigation is to collect high quality medical images of the Medtronic Market-Released DF4 lead in the shoulder and heart. Images collected during the study will allow for lead design and testing processes better tailored to the implanted environment.</brief_summary>
	<brief_title>Medtronic Market-Released DF4 Lead Imaging</brief_title>
	<detailed_description />
	<mesh_term>Tachycardia</mesh_term>
	<criteria>Patients greater than 18 years of age. Patients able and willing to attend imaging session. Patients able and willing to give informed consent. Patients with an implanted device/lead(s) for a minimum of 3 months. Subjects who require a legally authorized representative to obtain consent. Subjects with exclusion criteria required by local law (e.g. age, breastfeeding Pregnant women, or women of child bearing potential and who are not on a reliable form of birth control.</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
</DOC>